Understanding how different psychosocial treatments work for substance use disorders
Treatment Effect Heterogeneity in Psychosocial Treatments for Substance Use Disorders
This study is looking at how different therapy options for people dealing with substance use issues work for various types of patients, so we can find the best treatments that fit each person's needs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10888308 on NIH RePORTER |
What this research studies
This research investigates how various psychosocial treatments for substance use disorders affect different patients. By analyzing data from multiple clinical trials, the study aims to identify which treatment approaches are most effective for specific patient subgroups. The researchers will use advanced statistical methods to better understand the varying responses to these treatments, which could lead to more personalized care for individuals struggling with substance use. The goal is to improve treatment outcomes by tailoring interventions to the unique needs of each patient.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with substance use disorders who are seeking psychosocial treatment.
Not a fit: Patients who are not diagnosed with substance use disorders or those who are not interested in psychosocial treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for individuals with substance use disorders.
How similar studies have performed: Previous research has shown promise in using advanced statistical methods to analyze treatment effects, suggesting that this approach could yield valuable insights.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Susukida, Ryoko — Johns Hopkins University
- Study coordinator: Susukida, Ryoko
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.